Qube Research & Technologies LTD Outset Medical, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Outset Medical, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 25,836 shares of OM stock, worth $29,194. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,836
Previous 208,106
87.59%
Holding current value
$29,194
Previous $801,000
97.88%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding OM
# of Institutions
91Shares Held
19.9MCall Options Held
66.8KPut Options Held
60.3K-
Vanguard Group Inc Valley Forge, PA2.64MShares$2.99 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.89MShares$2.13 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.81MShares$2.05 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA1.47MShares$1.66 Million0.04% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.39MShares$1.57 Million0.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $54.2M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...